PIK3C3 Inhibition Promotes Sensitivity to Colon Cancer Therapy by Inhibiting Cancer Stem Cells

SIMPLE SUMMARY: Colorectal cancer (CRC) represents a heterogeneous population of tumor cells and cancer stem cells (CSCs) where CSCs are postulated to resist the chemotherapy, and support cancer malignancy. Eliminating CSC can therefore improve CRC therapy and patient survival; however, such strateg...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Balawant, Ahmad, Rizwan, Sharma, Swagat, Gowrikumar, Saiprasad, Primeaux, Mark, Rana, Sandeep, Natarajan, Amarnath, Oupicky, David, Hopkins, Corey R., Dhawan, Punita, Singh, Amar B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124755/
https://www.ncbi.nlm.nih.gov/pubmed/33946505
http://dx.doi.org/10.3390/cancers13092168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124755/
https://www.ncbi.nlm.nih.gov/pubmed/33946505
http://dx.doi.org/10.3390/cancers13092168

Ejemplares similares